UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR‐ACT) and long‐term extension study

European journal of heart failure, 2021-02, Vol.23 (2), p.277-285

2021

Volltextzugriff (PDF)

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

The New England journal of medicine, 2018-09, Vol.379 (11), p.1007-1016

2018

Volltextzugriff (PDF)

Evaluation of a Mathematical Model of Rat Body Weight Regulation in Application to Caloric Restriction and Drug Treatment Studies

PloS one, 2016-05, Vol.11 (5), p.e0155674

2016

Volltextzugriff (PDF)

Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial)

The American journal of cardiology, 2021-02, Vol.141, p.98-105

2021

Volltextzugriff (PDF)

Causes of Cardiovascular Hospitalization and Death in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial [ATTR-ACT])

The American journal of cardiology, 2021-06, Vol.148, p.146-150

2021

Volltextzugriff (PDF)

Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACT

JACC. Heart failure, 2021-02, Vol.9 (2), p.115-123

2021

Volltextzugriff (PDF)

The Bioequivalence of Tafamidis 61‐mg Free Acid Capsules and Tafamidis Meglumine 4 × 20‐mg Capsules in Healthy Volunteers

Clinical pharmacology in drug development, 2020-10, Vol.9 (7), p.849-854

2020

Volltextzugriff (PDF)

A 1-year analysis from a natural history study in Chinese individuals with Duchenne muscular dystrophy

The Lancet regional health. Western Pacific, 2024-01, Vol.42, p.100944-100944, Article 100944

2024

Volltextzugriff (PDF)

Pharmacological inhibition to examine the role of DGAT1 in dietary lipid absorption in rodents and humans

American journal of physiology: Gastrointestinal and liver physiology, 2013-06, Vol.304 (11), p.G958-G969

2013

Volltextzugriff (PDF)

Discovery and evaluation of spirocyclic derivatives as antagonists of the neuropeptide Y5 receptor

Bioorganic & medicinal chemistry letters, 2012-04, Vol.22 (8), p.2738-2743

2012

Volltextzugriff (PDF)

Design and synthesis of orally-active and selective azaindane 5HT2c agonist for the treatment of obesity

Bioorganic & medicinal chemistry letters, 2010, Vol.20 (1), p.266-271

2010

Volltextzugriff (PDF)

Orally active and brain permeable proline amides as highly selective 5HT2c agonists for the treatment of obesity

Bioorganic & medicinal chemistry letters, 2010-04, Vol.20 (7), p.2365-2369

2010

Volltextzugriff (PDF)

Discovery of a novel series of 6-azauracil-based thyroid hormone receptor ligands: potent, TRβ subtype-selective thyromimetics

Bioorganic & medicinal chemistry letters, 2003-02, Vol.13 (3), p.379-382

2003

Volltextzugriff (PDF)

CAUSES OF CARDIOVASCULAR HOSPITALIZATION AND DEATH IN THE TAFAMIDIS IN TRANSTHYRETIN CARDIOMYOPATHY CLINICAL TRIAL (ATTR-ACT)

Journal of the American College of Cardiology, 2020-03, Vol.75 (11), p.692-692

2020

Volltextzugriff (PDF)

In Vitro and in Vivo Characterization of 3-{2-[6-(2-tert-Butoxyethoxy)pyridin-3-yl]-1H-imidazol-4-yl}benzonitrile Hydrochloride Salt, a Potent and Selective NPY5 Receptor Antagonist

Journal of medicinal chemistry, 2003-02, Vol.46 (5), p.670-673

2003

Volltextzugriff (PDF)

Tafamidis Reduced the Decline in Health-Related Quality of Life in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT)

Journal of cardiac failure, 2019-08, Vol.25 (8), p.S7-S7

2019

Volltextzugriff (PDF)

Food intake in rhesus monkeys following central administration of orexins

Regulatory peptides, 2005-01, Vol.124 (1), p.209-214

2005

Volltextzugriff (PDF)

Efficacy and Safety of Tafamidis Doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT)

Journal of cardiac failure, 2019-08, Vol.25 (8), p.S77-S78

2019

Volltextzugriff (PDF)

A 1-year analysis from a natural history study in Chinese individuals with Duchenne muscular dystrophyResearch in context

The Lancet regional health. Western Pacific, 2024-01, Vol.42, p.100944

2024

Volltextzugriff (PDF)

Kappa opioid receptor-like immunoreactivity in guinea pig brain: Ultrastructural localization in presynaptic terminals in hippocampal formation

Journal of comparative neurology (1911), 1996-07, Vol.370 (3), p.377-395

1996

Volltextzugriff (PDF)

Sodium depletion and aldosterone decrease dopamine transporter activity in nucleus accumbens but not striatum

American journal of physiology. Regulatory, integrative and comparative physiology, 1999-05, Vol.276 (5), p.1339-R1345

1999

Volltextzugriff (PDF)

Dopamine transporter mRNA is increased in the CNS of Zucker fatty (fa/fa) rats

Brain research bulletin, 1998-06, Vol.46 (3), p.199-202

1998

Volltextzugriff (PDF)

Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy

JACC. Heart failure, 2021-02, Vol.9 (2), p.115-123

2021

Volltextzugriff (PDF)

Efficacy of Tafamidis in Transthyretin Amyloid Cardiomyopathy in the ATTR-ACT Trial: Sensitivity Analyses Further Support the Primary Results

Journal of cardiac failure, 2018-11, Vol.24 (11), p.813-813

2018

Volltextzugriff (PDF)

Oocytes from Xenopus laevis contain an intrinsic σ2-like binding site

Neuroscience letters, 1994-10, Vol.180 (2), p.159-162

1994

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(50)
Dissertationen
(1)

Sprache

Englisch
(51)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR‐ACT) and long‐term extension study

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

Evaluation of a Mathematical Model of Rat Body Weight Regulation in Application to Caloric Restriction and Drug Treatment Studies

Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial)

Causes of Cardiovascular Hospitalization and Death in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial [ATTR-ACT])

Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACT

The Bioequivalence of Tafamidis 61‐mg Free Acid Capsules and Tafamidis Meglumine 4 × 20‐mg Capsules in Healthy Volunteers

A 1-year analysis from a natural history study in Chinese individuals with Duchenne muscular dystrophy

Pharmacological inhibition to examine the role of DGAT1 in dietary lipid absorption in rodents and humans

Discovery and evaluation of spirocyclic derivatives as antagonists of the neuropeptide Y5 receptor

Design and synthesis of orally-active and selective azaindane 5HT2c agonist for the treatment of obesity

Orally active and brain permeable proline amides as highly selective 5HT2c agonists for the treatment of obesity

Discovery of a novel series of 6-azauracil-based thyroid hormone receptor ligands: potent, TRβ subtype-selective thyromimetics

CAUSES OF CARDIOVASCULAR HOSPITALIZATION AND DEATH IN THE TAFAMIDIS IN TRANSTHYRETIN CARDIOMYOPATHY CLINICAL TRIAL (ATTR-ACT)

In Vitro and in Vivo Characterization of 3-{2-[6-(2-tert-Butoxyethoxy)pyridin-3-yl]-1H-imidazol-4-yl}benzonitrile Hydrochloride Salt, a Potent and Selective NPY5 Receptor Antagonist

Tafamidis Reduced the Decline in Health-Related Quality of Life in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT)

Food intake in rhesus monkeys following central administration of orexins

Efficacy and Safety of Tafamidis Doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT)

A 1-year analysis from a natural history study in Chinese individuals with Duchenne muscular dystrophyResearch in context

Kappa opioid receptor-like immunoreactivity in guinea pig brain: Ultrastructural localization in presynaptic terminals in hippocampal formation

Sodium depletion and aldosterone decrease dopamine transporter activity in nucleus accumbens but not striatum

Dopamine transporter mRNA is increased in the CNS of Zucker fatty (fa/fa) rats

Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy

Efficacy of Tafamidis in Transthyretin Amyloid Cardiomyopathy in the ATTR-ACT Trial: Sensitivity Analyses Further Support the Primary Results

Oocytes from Xenopus laevis contain an intrinsic σ2-like binding site

Suchergebnisse filtern